Ir para o conteúdo [1]
Ir para o menu [2]
Ir para a busca [3]
Ir para o rodapé [4]

A-
A+

CONITEC

Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde

Página inicial > Recomendation Reports

Recomendation Reports

Publicado: Sexta, 11 de Setembro de 2020, 18h48 | Última atualização em Terça, 22 de Setembro de 2020, 16h07 | Acessos: 134

Find below the Health Technology Assessment Reports developed by Conitec.

Technology	HTA Report
Empagliflozin and Dapagliflozin	Nº 524 - March/2020 - Empagliflozin and Dapagliflozin for the treatment of Type 2 Diabetes Mellitus
Orlistat	Nº 523 - March/2020 - Orlistat for weight loss in overweight or obese patients
Sibutramine	Nº 522 - March/2020 - Sibutramine for the treatment of obese patients
Riociguat	Nº 519 - March/2020 - Riociguat for inoperable or persistent/recurrent after surgical treatment Chronic Thromboembolic Pulmonary Hypertension
Newborn Screening	Nº 516 - March/2020 - Newborn Screening for Congenital Toxoplasmosis
Dolutegravir	Nº 515 - March/2020 - Dolutegravir for the treatment of pregnant women living with HIV
Baricitinib (Olumiant®)	Nº 510 - March/2020 - Baricitinib (Olumiant®) for patients with moderate to severe Active Rheumatoid Arthritis
Mirabegron	Nº 509 - March/2020 - Mirabegron for the treatment of storage dysfunction in patients with Neurogenic Bladder
Oxybutynin, Tolterodine, Solifenacin a nd Darifenacin	Nº 508 - March/2020 - Antimuscarinics (Oxybutynin, Tolterodine, Solifenacin and Darifenacin) for the treatment of Storage Dysfunction in patients with Neurogenic Bladder
Photodynamic Therapy	Nº 507 - March/2020 - Photodynamic Therapy for non-melanoma skin câncer